Brookstone Capital Management’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
Other funds holding BSX
ATO
RG
YIH
FFM
ZIC
Brookstone Capital Management's BSX Position: Q2 2026 in Review
Brookstone Capital Management reduced its Boston Scientific (BSX) stake by 93% in Q2 2026, selling an estimated $12.7M and leaving 16,783 shares worth $716K. The position accounts for 0.01% of the portfolio, ranked #817.
Brookstone Capital Management first reported a position in BSX in Q2 2015 and has held it in 18 quarters since. The position peaked at $17.5M in Q4 2025. 303 funds tracked by Wall St. Rank hold BSX as of Q2 2026.
- Brookstone Capital Management held 16,783 shares of Boston Scientific worth $716K as of Q2 2026.
- Brookstone Capital Management sold 233,448 Boston Scientific shares in Q2 2026, an estimated $12.7M.
- Boston Scientific made up 0.01% of Brookstone Capital Management's portfolio in Q2 2026, its #817 holding.
- Brookstone Capital Management first reported a position in Boston Scientific in Q2 2015 and has held it in 18 quarters since.
- Brookstone Capital Management's Boston Scientific position peaked at $17.5M in Q4 2025.
- 303 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.
Based on Brookstone Capital Management's 13F filing for Q2 2026, filed 15 Jul 2026.